Medindia
Medindia LOGIN REGISTER
Advertisement

Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Non-Small Cell Lung Cancer

Thursday, May 19, 2016 Respiratory Disease News
Advertisement

Source: Report of Statistical Analysis for NCIC CTG Protocol Number IND.211

1 This was an interim analysis, as 38 (25.0%) patients out of a total of 152 patients were alive at the time of data cut-off. Survival outcomes noted could change at final analysis.

2 Mutated

Sponsored Post and Backlink Submission


Latest Press Release on Respiratory Disease News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close